GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...

Business growth consultancy, 24HR Business Plan (24HRBP), has unveiled its newest offering: the 24 Hour High Performance ...

It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...

The FTSE 100 was up 0.2 per cent after the first hour of trading, having finished on a record high of 8,871.31 on Thursday.

NHS England has confirmed that it will be the first health system worldwide to roll out the treatment. The drug will be ...

Built on the premise that only 30 per cent of workplace teams are considered high performing is tough to hear!

A “TROJAN HORSE” therapy that sneaks toxic drugs inside and kills cancer cells is being rolled out on the NHS in England in a ...

Therapeutics Market is projected to be valued at USD 962.4 million in 2025, reaching USD 1,523.4 million by 2035, with a compound annual growth rate (CAGR) of 4.7% during the forecast period. The ...

Business Plan has introduced a data-driven coaching program to help leadership teams improve performance.The ...

MANILA, Philippines — Watsons Philippines gathered the brilliant names in the health, wellness and beauty industry for its ...

The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52 ...